PD
NAUT icon

Point72 (DIFC)’s Nautilus Biotechnolgy NAUT Stock Holding History

Point72 (DIFC)’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$667 Hold
789
– – ﹤0.01% 1073
2025
Q2 		$572 Buy
+789
New +$593 ﹤0.01% 1456
2025
Q1 		– Sell
-1,841
Closed -$3.09K – 1927
2024
Q4 		$3.09K Buy
+1,841
New +$4.4K ﹤0.01% 1410

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $2.32B AUM 30.12% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $2.63B AUM 20.53% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Point72 (DIFC)'s NAUT Position: Q3 2025 in Review

Point72 (DIFC) held its Nautilus Biotechnolgy (NAUT) position steady in Q3 2025 at 789 shares worth $667. The position accounts for ﹤0.01% of the portfolio, ranked #1073.

Point72 (DIFC) first reported a position in NAUT in Q4 2024 and has held it in 3 quarters since. The position peaked at $3.09K in Q4 2024. 68 funds tracked by Wall St. Rank hold NAUT as of Q3 2025.

  • Point72 (DIFC) held 789 shares of Nautilus Biotechnolgy worth $667 as of Q3 2025.
  • Point72 (DIFC) left its Nautilus Biotechnolgy share count unchanged in Q3 2025.
  • Nautilus Biotechnolgy made up ﹤0.01% of Point72 (DIFC)'s portfolio in Q3 2025, its #1073 holding.
  • Point72 (DIFC) first reported a position in Nautilus Biotechnolgy in Q4 2024 and has held it in 3 quarters since.
  • Point72 (DIFC)'s Nautilus Biotechnolgy position peaked at $3.09K in Q4 2024.
  • 68 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.